全文获取类型
收费全文 | 7379篇 |
免费 | 700篇 |
国内免费 | 131篇 |
专业分类
耳鼻咽喉 | 145篇 |
儿科学 | 154篇 |
妇产科学 | 63篇 |
基础医学 | 988篇 |
口腔科学 | 76篇 |
临床医学 | 624篇 |
内科学 | 946篇 |
皮肤病学 | 69篇 |
神经病学 | 838篇 |
特种医学 | 193篇 |
外国民族医学 | 1篇 |
外科学 | 440篇 |
综合类 | 1020篇 |
一般理论 | 1篇 |
预防医学 | 1092篇 |
眼科学 | 79篇 |
药学 | 835篇 |
7篇 | |
中国医学 | 317篇 |
肿瘤学 | 322篇 |
出版年
2024年 | 31篇 |
2023年 | 189篇 |
2022年 | 291篇 |
2021年 | 408篇 |
2020年 | 383篇 |
2019年 | 384篇 |
2018年 | 365篇 |
2017年 | 294篇 |
2016年 | 254篇 |
2015年 | 231篇 |
2014年 | 526篇 |
2013年 | 670篇 |
2012年 | 430篇 |
2011年 | 503篇 |
2010年 | 412篇 |
2009年 | 340篇 |
2008年 | 403篇 |
2007年 | 335篇 |
2006年 | 290篇 |
2005年 | 227篇 |
2004年 | 187篇 |
2003年 | 161篇 |
2002年 | 117篇 |
2001年 | 97篇 |
2000年 | 87篇 |
1999年 | 67篇 |
1998年 | 61篇 |
1997年 | 45篇 |
1996年 | 40篇 |
1995年 | 43篇 |
1994年 | 43篇 |
1993年 | 24篇 |
1992年 | 31篇 |
1991年 | 24篇 |
1990年 | 20篇 |
1989年 | 26篇 |
1988年 | 14篇 |
1987年 | 9篇 |
1986年 | 10篇 |
1985年 | 26篇 |
1984年 | 14篇 |
1983年 | 13篇 |
1982年 | 11篇 |
1981年 | 8篇 |
1980年 | 9篇 |
1976年 | 7篇 |
1975年 | 12篇 |
1974年 | 6篇 |
1973年 | 7篇 |
1972年 | 6篇 |
排序方式: 共有8210条查询结果,搜索用时 15 毫秒
1.
目的 基于文本挖掘技术和生物医学数据库对新型冠状病毒肺炎(COVID-19)相关文献进行数据挖掘分析,探究COVID-19及其主要症状发热、咳嗽、呼吸障碍相关基因靶点,筛选潜在有效的化学药和中药。方法 使用GenCLiP 3网站获取COVID-19和其主要症状咳嗽、发热、呼吸障碍共4个关键词的共有靶点,在METASCAPE数据库中对其进行基因本体(GO)和通路富集分析,再利用String数据库和Cytoscape软件构建共有靶点的蛋白质相互作用网络,筛选获得核心基因,运用DGIdb数据库、SymMap数据库针对核心基因进行中西医治疗药物预测。结果 获得COVID-19及其主要症状共有基因靶点28个,其中有IL2、IL1B、CCL2等核心基因16个,使用DGIdb数据库筛选获得与16个关键靶点相互作用的化学药包括沙利度胺、来氟米特、环孢素等28种,中药包括虎杖、黄芪、芦荟等70味。结论 COVID-19及其主要症状的病理机制可能和CD4、KNG1、VEGFA等28个共有基因相关,可能通过介导TNF、IL-17等信号通路参与COVID-19病理过程。潜在有效药物可能通过作用相关靶点通路起到治疗COVID-19的作用。 相似文献
2.
目的:探索嘌呤能受体X1(purinergic receptor,P2RX1)与肺腺癌(LUAD)患者预后及免疫细胞浸润的相关性。方法:利用生物信息学技术分析非小细胞肺癌中P2RX1的表达及其甲基化与患者预后的关系,对P2RX1共表达基因进行富集分析并筛选核心基因。利用TIMER 2.0数据库、R软件等分析P2RX1与免疫细胞、免疫检查点、免疫基质评分等的相关性。结果:P2RX1在LUAD中表达下调,低表达P2RX1的患者预后较差(P<0.05),且P2RX1与肿瘤纯度、分期等临床病理因素有关(P<0.05)。P2RX1的表达与肺鳞癌患者预后无明显相关。Cg06475633等P2RX1 CpG位点甲基化与患者预后相关。P2RX1共表达基因主要富集于免疫细胞活化、分化等通路和生物学进程,核心基因主要包括BTK、IKZF1等。P2RX1的表达与B细胞浸润、免疫/基质评分、PD-1、CTLA-4等多个免疫检查点显著相关(P<0.05)。结论:P2RX1有望成为LUAD诊断和免疫治疗的新靶点。 相似文献
3.
4.
目的:分析临床检验不合格血液标本的原因为何,研究相应的质量改进方法。方法:本课题自我院检验血液标本样本中抽取140份,其中2018年2月~2019年3月的70份命名成对照组,2019年4月~2020年3月的70份命名成试验组,前一组未进行质量改进,后一组进行质量改进,比较检验结果有何不同。结果:试验组这组的检验标本不合格率要比对照组那组的检验标本不合格率低,数据上是P<0.05的情况,即表明有统计学意义。结论:凝血反应、溶血反应、样本问题、送检失误、抗凝不全等是导致临床检验不合格血液标本的原因所在,实施质量改进可将血液标本质量提高。 相似文献
5.
Precise data on food chemical composition is crucial for any quantitative nutrition research and indispensable for evaluation and planning of computer-based menus. Moreover, exact food chemical composition is of the utmost importance in composing specific diets that may be low in certain essential nutrients. Therefore, this research evaluated a weekly vegan menu using three different food composition databases (FCDB): the Croatian, the official Danish Food Composition Database and the United States Department of Agriculture (USDA) – National Nutrient Database for Standard Reference. Significant differences (p < 0.05) were determined in evaluated and optimised offers for the same menu when using different FCDBs. Furthermore, in these menus quantities of some nutrients have not reached official daily recommendations needed for prevention of non-communicable diseases. In this research, new vegan menus that can provide adequate quantity of essential nutrients, regardless of FCDB utilized, were created with linear optimisation (LO). This resulted in high quality daily menu offers. However, depending on the FCDB that was used, optimal menus differed in daily meal combinations, and the effectiveness of the optimisation in the minimisation of differences caused by differences of data in FCDBs was tested. Linear optimisation has been proved to be an effective tool in planning of specific diets, such as vegan diets. Nonetheless, the quality of computer-planned menus depends heavily on the quality of FCDB used. 相似文献
6.
7.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2022,34(2):e97-e103
Modern artificial intelligence techniques have solved some previously intractable problems and produced impressive results in selected medical domains. One of their drawbacks is that they often need very large amounts of data. Pre-existing datasets in the form of national cancer registries, image/genetic depositories and clinical datasets already exist and have been used for research. In theory, the combination of healthcare Big Data with modern, data-hungry artificial intelligence techniques should offer significant opportunities for artificial intelligence development, but this has not yet happened. Here we discuss some of the structural reasons for this, barriers preventing artificial intelligence from making full use of existing datasets, and make suggestions as to enable progress. To do this, we use the framework of the 6Vs of Big Data and the FAIR criteria for data sharing and availability (Findability, Accessibility, Interoperability, and Reuse). We share our experience in navigating these barriers through The Brain Tumour Data Accelerator, a Brain Tumour Charity-supported initiative to integrate fragmented patient data into an enriched dataset. We conclude with some comments as to the limits of such approaches. 相似文献
8.
9.
《Vaccine》2021,39(34):4759-4765
Dengue vaccination would enhance the control of dengue, one of the most frequent vector-borne viral diseases globally. CYD-TDV is the first dengue vaccine to be licensed, but global uptake has been hampered due to its use being limited to seropositive persons aged 9 years and above, and the need for a 3-dose schedule. The Partnership for Dengue Control (PDC) organized a meeting with key opinion leaders and stakeholders to deliberate on implementation strategies for the use of CYD-TDV. New data have emerged that support the shortening of the primary schedule from a 3 to 2 dose schedule, extending the age range below 9 to 6 years of age, and expanding the indication from endemic populations to also include travelers to endemic areas. Cost-effectiveness may improve with the modified 2-dose regimen and with multiple testing. Strategies to implement a dengue vaccination program have been developed, in particular school-based strategies. A range of delivery scenarios can then be considered, using various settings for each step of the intervention. However, several challenges remain, including communication about limiting the use of this vaccine to seropositive individuals only. Affordability will vary from country to country, as will government commitment and community acceptance. Well-tailored communication strategies that target key stakeholders are expected to make up a significant part of any future dengue vaccination program. 相似文献
10.